Empfehlungen zur Malariaprophylaxe

Key words

travel medicine - malaria - repellents - chemoprophylaxis

• Literatur

• 1 World Health Organization. World malaria report. 2019 Im Internet www.who.int/malaria/publications/world-malaria-report-2019/en/
• 2 Falkenhorst G, Enkelmann J, Lachmann R. et al Zur Situation bei wichtigen Infektionskrankheiten, reiseassoziierte Krankheiten 2018. Epid Bull 2019; 48: 513-321
• 3 Amato R, Pearson RD, Almagro-Garcia J. et al Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study. Lancet Infect Dis 2018; 18: 337-345
• 4 Parr JB, Verity R, Doctor SM. et al Pfhrp2-Deleted Plasmodium falciparum Parasites in the Democratic Republic of the Congo: A National Cross-sectional Survey. J Infect Dis 2017; 216: 36-44
• 5 Plucinski MM, Herman C, Jones S. et al Screening for Pfhrp2/3-Deleted Plasmodium falciparum, Non-falciparum, and Low-Density Malaria Infections by a Multiplex Antigen Assay. J Infect Dis 2019; 219: 437-447
• 6 Fradin MS. Insect Protection. In Keystone J, Kozarsky P, Connor B, Nothdurft H, Mendelson M, Leder K. eds Travel Medicine. Elsevier 2019: 43-52
• 7 The Medical Letter Inc. Insect Repellents. The Medical Letter on Drugs and Therapeutics 2019: 61 (Issue 1579)
• 8 Stanczyk NM, Behrens RH, Chen-Hussey V. et al Mosquito repellents for travellers. BMJ 2015; 350: h99
• 9 Lupi E, Hatz C, Schlagenhauf P. The efficacy of repellents against Aedes, Anopheles, Culex and Ixodes spp. – a literature review. Travel Med Infect Dis 2013; 11: 374-411
• 10 Vinnemeier CD, Rothe C, Kreuels B. et al Response to fever and utilization of standby emergency treatment (SBET) for malaria in travellers to Southeast Asia: a questionnaire-based cohort study. Malar J 2017; 16: 44
• 11 Tan R, Elmers J, Genton B. Malaria standby emergency treatment (SBET) for travellers visiting malaria endemic areas: a systematic review and meta-analysis. J Travel Med 2019; 26: pii: taz027
• 12 Ferrara P, Masuet-Aumatell C, Agüero F. et al The use of stand-by emergency treatment (SBET) for malaria in travellers: A systematic review and meta-analysis of observational studies. J Infect 2018; 77: 455-462
• 13 Ferrara P, Masuet-Aumatell C, Agüero F. et al Stand-by emergency treatment (SBET) of malaria in Spanish travellers: a cohort study. Malar J 2018; 17: 134
• 14 Cheplapharm Arzneimittel GmbH. Patientenpass für Lariam (Mefloquin). Im Internet www.cheplapharm.com/fileadmin/Ablage/Downloads/Educational_Material/Lariam/AT_Austria/Patientenpass-Lariam-AT_122018.pdf
• 15 Chan XHS, Win YN, Mawer LJ. et al Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis. Lancet Infect Dis 2018; 18: 913-923
• 16 Kurth F, Develoux M, Mechain M. et al Severe malaria in Europe: an 8-year multi-centre observational study. Malar J 2017; 16: 57
• 17 Kurth F, Lingscheid T, Steiner F. et al Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria. Emerg Infect Dis 2016; 22: 1381-1386
• 18 Froeschl G, Nothdurft HD, von Sonnenburg F. et al Retrospective clinical case series study in 2017 identifies Plasmodium knowlesi as most frequent Plasmodium species in returning travellers from Thailand to Germany. Euro Surveill 2018: 23
• 19 Deutsche Gesellschaft für Tropenmedizin und Globale Gesundheit. Leitlinie: Diagnostik und Therapie der Malarie. Version Juli 2016. Im Internet www.awmf.org/uploads/tx_szleitlinien/042-001l_S1_Malaria_Diagnostik_Therapie_2016-08.pdf
• 20 Kolifarhood G, Raeisi A, Ranjbar M. et al Prophylactic efficacy of primaquine for preventing Plasmodium falciparum and Plasmodium vivax parasitaemia in travelers: A meta-analysis and systematic review. Travel Med Infect Dis 2017; 17: 5-18
• 21 Baird JK. Tafenoquine for travelers’ malaria: evidence, rationale and recommendations. J Travel Med 2018: 25
• 22 Lagarce L, Lerolle N, Asfar P. et al A non-pharmaceutical form of Artemisia annua is not effective in preventing Plasmodium falciparum malaria. J Travel Med 2016: 23
• 23 Pays JF. Threats to the Effectiveness of Malaria Treatment. Bull Soc Pathol Exot 2018; 111: 197-198
• 24 World Health Organization. WHO technical document of the use of non-pharmaceutical forms of Artemisia In: WHO (ed.). Malaria Policy Advisory Committee Meeting 2–4 October 2019. Geneva 2019
• 25 Albright TA, Binns HJ, Katz BZ. Side effects of and compliance with malaria prophylaxis in children. J Travel Med 2002; 9: 289-292
• 26 Emryotox.de. Doxycyclin. 2017 Im Internet www.embryotox.de/arzneimittel/details/doxycyclin/
• 27 HIV Drug Interactions. Interaction Checker. Im Internet www.hiv-druginteractions.org
• 28 Infrastruktur BfVud (ed.). Seeärztlicher Dienst DSBV. Malaria-Merkblatt. Hamburg 2018: 8
• 29 Metzger WG, Sulyok Z, Theurer A. et al [Development of malaria vaccines-state of the art]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2020; 63: 45-55
• 30 von Seidlein L. The Advanced Development Pathway of the RTS,S/AS01 Vaccine. Methods Mol Biol 2019; 2013: 177-187
• 31 Adepoju P. RTS,S malaria vaccine pilots in three African countries. Lancet 2019; 393: 1685
• 32 Mordmuller B, Supan C, Sim KL. et al Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres. Malar J 2015; 14: 117
• 33 Mordmuller B, Surat G, Lagler H. et al Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature 2017; 542: 445-449
• 34 Lyke KE, Ishizuka AS, Berry AA. et al Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. Proc Natl Acad Sci U S A 2017; 114: 2711-2716
• 35 Butler D. Promising malaria vaccine to be tested in first large field trial. Nature 2019 Apr 16 [Online ahead of print]
• 36 Theisen M, Adu B, Mordmuller B. et al The GMZ2 malaria vaccine: from concept to efficacy in humans. Expert Rev Vaccines 2017; 16: 907-917
• 37 Mordmuller B, Sulyok M, Egger-Adam D. et al First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria. Clin Infect Dis 2019; 69: 1509-1516
• 38 Schlagenhauf P, Wilson ME, Petersen E, MbCarthy A, Chen LH. Malaria Chemoprophylaxis. In Keystone J, Kozarsky P, Connor B, Nothdurft H, Mendelson M, Leder K. eds Travel Medicine. Elsevier 2019: 145-167
• 39 Bundesamt für Gesundheit (BAG) und Expertenkomitee für Reisemedizin (EKRM). Malariaschutz für Kurzzeitaufenthalter (Reisen bis zu 3 Monaten). Stand Januar 2016 Im Internet www.bag.admin.ch/bag/de/home/das-bag/publikationen/periodika/bag-bulletin.html
• 40 Schweizerisches Expertenkomitee für Reisemedizin (EKRM). Aktualisierte Empfehlungen des Schweizerischen Expertenkomitees für Reisemedizin zur Prävention einer Malaria bei Reisenden 2019: angepasster Einsatz der notfallmässigen Selbstbehandlung (NSB) und der medikamentösen Prophylaxe. BAG-Bulletin 30 vom 22. Juli 2019